{"transactions":[{"id":4634913,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Units","published_at":"2026-10-03T01:01:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") converts into one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Up to 135,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain regulatory milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones."}],"balance_after":135000,"derivative":{"underlying":"Common stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-26-113342","document":"tm2626734-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926113342/tm2626734-2_4seq1.xml","form_type":"4"}},{"id":4634912,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-10-03T01:01:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":180000,"derivative":{"underlying":"Common stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001104659-26-113342","document":"tm2626734-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926113342/tm2626734-2_4seq1.xml","form_type":"4"}},{"id":4634911,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-10-03T01:01:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":135000,"derivative":{"exercise_price":14.82,"expiration_date":"2036-09-30","underlying":"Common stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-26-113342","document":"tm2626734-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926113342/tm2626734-2_4seq1.xml","form_type":"4"}},{"id":4614875,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-09-10T21:01:32.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":15626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":93756,"derivative":{"underlying":"Common stock","underlying_shares":15626},"source":{"system":"sec-edgar","filing":"0001104659-26-106752","document":"tm2625111-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926106752/tm2625111-3_4seq1.xml","form_type":"4"}},{"id":4614874,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-10T21:01:32.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":6638,"price":8.7,"value":57750.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":595447,"source":{"system":"sec-edgar","filing":"0001104659-26-106752","document":"tm2625111-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926106752/tm2625111-3_4seq1.xml","form_type":"4"}},{"id":4614873,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-10T21:01:32.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":15626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":602085,"source":{"system":"sec-edgar","filing":"0001104659-26-106752","document":"tm2625111-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926106752/tm2625111-3_4seq1.xml","form_type":"4"}},{"id":4614872,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-10T21:00:55.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":46878,"derivative":{"underlying":"Common stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001104659-26-106750","document":"tm2625111-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1594604/000110465926106750/tm2625111-2_4seq1.xml","form_type":"4"}},{"id":4614871,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:00:55.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":3976,"price":8.7,"value":34591.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":142074,"source":{"system":"sec-edgar","filing":"0001104659-26-106750","document":"tm2625111-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1594604/000110465926106750/tm2625111-2_4seq1.xml","form_type":"4"}},{"id":4614870,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:00:55.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":146050,"source":{"system":"sec-edgar","filing":"0001104659-26-106750","document":"tm2625111-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1594604/000110465926106750/tm2625111-2_4seq1.xml","form_type":"4"}},{"id":4614869,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-10T21:00:19.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":58599,"derivative":{"underlying":"Common stock","underlying_shares":9766},"source":{"system":"sec-edgar","filing":"0001104659-26-106748","document":"tm2625111-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926106748/tm2625111-1_4seq1.xml","form_type":"4"}},{"id":4614868,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:00:19.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":4478,"price":8.7,"value":38958.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":256364,"source":{"system":"sec-edgar","filing":"0001104659-26-106748","document":"tm2625111-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926106748/tm2625111-1_4seq1.xml","form_type":"4"}},{"id":4614867,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:00:19.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":260842,"source":{"system":"sec-edgar","filing":"0001104659-26-106748","document":"tm2625111-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926106748/tm2625111-1_4seq1.xml","form_type":"4"}},{"id":3039,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T21:02:48.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":83338,"derivative":{"underlying":"Common stock","underlying_shares":41669},"source":{"system":"sec-edgar","filing":"0001104659-26-105101","document":"tm2624648-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926105101/tm2624648-3_4seq1.xml","form_type":"4"}},{"id":3038,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-03T21:02:48.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":17702,"price":8.28,"value":146572.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":586459,"source":{"system":"sec-edgar","filing":"0001104659-26-105101","document":"tm2624648-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926105101/tm2624648-3_4seq1.xml","form_type":"4"}},{"id":3037,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-03T21:02:48.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":604161,"source":{"system":"sec-edgar","filing":"0001104659-26-105101","document":"tm2624648-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926105101/tm2624648-3_4seq1.xml","form_type":"4"}},{"id":3032,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T21:02:10.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":5470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":10939,"derivative":{"underlying":"Common stock","underlying_shares":5470},"source":{"system":"sec-edgar","filing":"0001104659-26-105100","document":"tm2624648-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926105100/tm2624648-2_4seq1.xml","form_type":"4"}},{"id":3031,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-09-03T21:02:10.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2508,"price":8.28,"value":20766.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":251076,"source":{"system":"sec-edgar","filing":"0001104659-26-105100","document":"tm2624648-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926105100/tm2624648-2_4seq1.xml","form_type":"4"}},{"id":3030,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-09-03T21:02:10.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":5470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":253584,"source":{"system":"sec-edgar","filing":"0001104659-26-105100","document":"tm2624648-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926105100/tm2624648-2_4seq1.xml","form_type":"4"}},{"id":3014,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T21:00:25.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":8789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":17580,"derivative":{"underlying":"Common stock","underlying_shares":8789},"source":{"system":"sec-edgar","filing":"0001104659-26-105099","document":"tm2624648-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1594604/000110465926105099/tm2624648-1_4seq1.xml","form_type":"4"}},{"id":3013,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-03T21:00:25.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4472,"price":8.28,"value":37028.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":138237,"source":{"system":"sec-edgar","filing":"0001104659-26-105099","document":"tm2624648-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1594604/000110465926105099/tm2624648-1_4seq1.xml","form_type":"4"}},{"id":3012,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-03T21:00:25.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":8789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":142709,"source":{"system":"sec-edgar","filing":"0001104659-26-105099","document":"tm2624648-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1594604/000110465926105099/tm2624648-1_4seq1.xml","form_type":"4"}},{"id":689529,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-12T21:30:12.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":10001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":60003,"derivative":{"underlying":"Common Stock","underlying_shares":10001},"source":{"system":"sec-edgar","filing":"0001104659-26-095040","document":"tm2622903-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926095040/tm2622903-1_4seq1.xml","form_type":"4"}},{"id":689528,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T21:30:12.000Z","date":"2026-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2436,"price":6.4,"value":15590.4,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":154511,"source":{"system":"sec-edgar","filing":"0001104659-26-095040","document":"tm2622903-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926095040/tm2622903-1_4seq1.xml","form_type":"4"}},{"id":689527,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T21:30:12.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":10001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":156947,"source":{"system":"sec-edgar","filing":"0001104659-26-095040","document":"tm2622903-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926095040/tm2622903-1_4seq1.xml","form_type":"4"}},{"id":691804,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-10T21:30:12.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":49995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on August 6, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":100005,"derivative":{"underlying":"Common Stock","underlying_shares":49995},"source":{"system":"sec-edgar","filing":"0001104659-26-093482","document":"tm2622610-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926093482/tm2622610-1_4seq1.xml","form_type":"4"}},{"id":691803,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-10T21:30:12.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":21238,"price":6.21,"value":131887.98,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":28757,"source":{"system":"sec-edgar","filing":"0001104659-26-093482","document":"tm2622610-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926093482/tm2622610-1_4seq1.xml","form_type":"4"}},{"id":691802,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-10T21:30:12.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":49995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":49995,"source":{"system":"sec-edgar","filing":"0001104659-26-093482","document":"tm2622610-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926093482/tm2622610-1_4seq1.xml","form_type":"4"}},{"id":731905,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2026-06-18T21:17:32.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":90316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":90316,"derivative":{"underlying":"Common Stock","underlying_shares":90316},"source":{"system":"sec-edgar","filing":"0001104659-26-075863","document":"tm2618145-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926075863/tm2618145-5_4seq1.xml","form_type":"4"}},{"id":731903,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":30609,"kind":"person","name":"Dukes Iain D.","position":1,"cik":"0001681955","reported_name":"Dukes Iain D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2026-06-18T21:16:56.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":180632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":180632,"derivative":{"underlying":"Common Stock","underlying_shares":180632},"source":{"system":"sec-edgar","filing":"0001104659-26-075861","document":"tm2618145-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926075861/tm2618145-4_4seq1.xml","form_type":"4"}},{"id":731902,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36776,"kind":"person","name":"Countouriotis Athena","position":1,"cik":"0001571469","reported_name":"Countouriotis Athena","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2026-06-18T21:16:26.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":90316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":90316,"derivative":{"underlying":"Common Stock","underlying_shares":90316},"source":{"system":"sec-edgar","filing":"0001104659-26-075858","document":"tm2618145-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926075858/tm2618145-3_4seq1.xml","form_type":"4"}},{"id":731904,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36777,"kind":"person","name":"Maynard Ryan D","position":1,"cik":"0001363984","reported_name":"Maynard Ryan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2026-06-18T21:15:50.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":90316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":90316,"derivative":{"underlying":"Common Stock","underlying_shares":90316},"source":{"system":"sec-edgar","filing":"0001104659-26-075856","document":"tm2618145-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926075856/tm2618145-2_4seq1.xml","form_type":"4"}},{"id":732437,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-18T21:15:17.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":15000,"derivative":{"underlying":"Common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-075854","document":"tm2618145-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926075854/tm2618145-1_4seq1.xml","form_type":"4"}},{"id":745005,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:00:49.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":68365,"derivative":{"underlying":"Common stock","underlying_shares":9766},"source":{"system":"sec-edgar","filing":"0001104659-26-071895","document":"tm2617137-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926071895/tm2617137-2_4seq1.xml","form_type":"4"}},{"id":745004,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:00:49.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":3843,"price":4.23,"value":16255.89,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":248114,"source":{"system":"sec-edgar","filing":"0001104659-26-071895","document":"tm2617137-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926071895/tm2617137-2_4seq1.xml","form_type":"4"}},{"id":745003,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:00:49.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":251957,"source":{"system":"sec-edgar","filing":"0001104659-26-071895","document":"tm2617137-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926071895/tm2617137-2_4seq1.xml","form_type":"4"}},{"id":744501,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:00:10.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":54691,"derivative":{"underlying":"Common stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001104659-26-071891","document":"tm2617137-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926071891/tm2617137-1_4seq1.xml","form_type":"4"}},{"id":744500,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:00:10.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":3976,"price":4.23,"value":16818.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":133920,"source":{"system":"sec-edgar","filing":"0001104659-26-071891","document":"tm2617137-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926071891/tm2617137-1_4seq1.xml","form_type":"4"}},{"id":744499,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:00:10.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":137896,"source":{"system":"sec-edgar","filing":"0001104659-26-071891","document":"tm2617137-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926071891/tm2617137-1_4seq1.xml","form_type":"4"}},{"id":744697,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-06-09T17:03:00.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":109382,"derivative":{"underlying":"Common stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001104659-26-071899","document":"tm2617137-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926071899/tm2617137-4_4seq1.xml","form_type":"4"}},{"id":744696,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-09T17:03:00.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6638,"price":4.23,"value":28078.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":562492,"source":{"system":"sec-edgar","filing":"0001104659-26-071899","document":"tm2617137-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926071899/tm2617137-4_4seq1.xml","form_type":"4"}},{"id":744695,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-09T17:03:00.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":569130,"source":{"system":"sec-edgar","filing":"0001104659-26-071899","document":"tm2617137-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926071899/tm2617137-4_4seq1.xml","form_type":"4"}},{"id":744720,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-09T17:01:29.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":54691,"derivative":{"underlying":"Common stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001104659-26-071897","document":"tm2617137-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926071897/tm2617137-3_4seq1.xml","form_type":"4"}},{"id":744719,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-09T17:01:29.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":3976,"price":4.23,"value":16818.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":140111,"source":{"system":"sec-edgar","filing":"0001104659-26-071897","document":"tm2617137-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926071897/tm2617137-3_4seq1.xml","form_type":"4"}},{"id":744718,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-09T17:01:29.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":144087,"source":{"system":"sec-edgar","filing":"0001104659-26-071897","document":"tm2617137-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926071897/tm2617137-3_4seq1.xml","form_type":"4"}},{"id":751833,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-06-03T21:02:06.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":41668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":125007,"derivative":{"underlying":"Common stock","underlying_shares":41668},"source":{"system":"sec-edgar","filing":"0001104659-26-070155","document":"tm2616710-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926070155/tm2616710-4_4seq1.xml","form_type":"4"}},{"id":751832,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-03T21:02:06.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":17701,"price":3.96,"value":70095.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":553505,"source":{"system":"sec-edgar","filing":"0001104659-26-070155","document":"tm2616710-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926070155/tm2616710-4_4seq1.xml","form_type":"4"}},{"id":751831,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-03T21:02:06.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":41668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":571206,"source":{"system":"sec-edgar","filing":"0001104659-26-070155","document":"tm2616710-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926070155/tm2616710-4_4seq1.xml","form_type":"4"}},{"id":752348,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-03T21:01:23.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":5469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":16409,"derivative":{"underlying":"Common stock","underlying_shares":5469},"source":{"system":"sec-edgar","filing":"0001104659-26-070153","document":"tm2616710-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926070153/tm2616710-3_4seq1.xml","form_type":"4"}},{"id":752347,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:01:23.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2508,"price":3.96,"value":9931.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":242191,"source":{"system":"sec-edgar","filing":"0001104659-26-070153","document":"tm2616710-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926070153/tm2616710-3_4seq1.xml","form_type":"4"}},{"id":752346,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:01:23.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":5469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":244699,"source":{"system":"sec-edgar","filing":"0001104659-26-070153","document":"tm2616710-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926070153/tm2616710-3_4seq1.xml","form_type":"4"}},{"id":751884,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-03T21:00:43.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":26369,"derivative":{"underlying":"Common stock","underlying_shares":8790},"source":{"system":"sec-edgar","filing":"0001104659-26-070152","document":"tm2616710-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926070152/tm2616710-2_4seq1.xml","form_type":"4"}},{"id":751883,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:00:43.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4473,"price":3.96,"value":17713.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":136274,"source":{"system":"sec-edgar","filing":"0001104659-26-070152","document":"tm2616710-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926070152/tm2616710-2_4seq1.xml","form_type":"4"}},{"id":751882,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:00:43.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":140747,"source":{"system":"sec-edgar","filing":"0001104659-26-070152","document":"tm2616710-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926070152/tm2616710-2_4seq1.xml","form_type":"4"}},{"id":751495,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-03T21:00:24.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":26369,"derivative":{"underlying":"Common stock","underlying_shares":8790},"source":{"system":"sec-edgar","filing":"0001104659-26-070149","document":"tm2616710-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926070149/tm2616710-1_4seq1.xml","form_type":"4"}},{"id":751494,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:00:24.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4473,"price":3.96,"value":17713.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":130083,"source":{"system":"sec-edgar","filing":"0001104659-26-070149","document":"tm2616710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926070149/tm2616710-1_4seq1.xml","form_type":"4"}},{"id":751493,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:00:24.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":134556,"source":{"system":"sec-edgar","filing":"0001104659-26-070149","document":"tm2616710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926070149/tm2616710-1_4seq1.xml","form_type":"4"}},{"id":781142,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-13T21:00:25.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":70004,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-26-060356","document":"tm2614425-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926060356/tm2614425-1_4seq1.xml","form_type":"4"}},{"id":781141,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-13T21:00:25.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2435,"price":3.7,"value":9009.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":146946,"source":{"system":"sec-edgar","filing":"0001104659-26-060356","document":"tm2614425-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926060356/tm2614425-1_4seq1.xml","form_type":"4"}},{"id":781140,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-13T21:00:25.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":149381,"source":{"system":"sec-edgar","filing":"0001104659-26-060356","document":"tm2614425-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926060356/tm2614425-1_4seq1.xml","form_type":"4"}},{"id":848564,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:25:27.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":132200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":132200,"derivative":{"underlying":"Common stock","underlying_shares":132200},"source":{"system":"sec-edgar","filing":"0001104659-26-026475","document":"tm268453-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926026475/tm268453-5_4seq1.xml","form_type":"4"}},{"id":848711,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:07:57.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":235000,"derivative":{"underlying":"Common stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0001104659-26-026457","document":"tm268453-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926026457/tm268453-6_4seq1.xml","form_type":"4"}},{"id":849132,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:04:33.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":117500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":117500,"derivative":{"underlying":"Common stock","underlying_shares":117500},"source":{"system":"sec-edgar","filing":"0001104659-26-026451","document":"tm268453-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926026451/tm268453-4_4seq1.xml","form_type":"4"}},{"id":848756,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:02:27.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":58750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":58750,"derivative":{"underlying":"Common stock","underlying_shares":58750},"source":{"system":"sec-edgar","filing":"0001104659-26-026448","document":"tm268453-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926026448/tm268453-3_4seq1.xml","form_type":"4"}},{"id":849142,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:01:07.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":132200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":132200,"derivative":{"underlying":"Common Stock","underlying_shares":132200},"source":{"system":"sec-edgar","filing":"0001104659-26-026444","document":"tm268453-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926026444/tm268453-2_4seq1.xml","form_type":"4"}},{"id":848563,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:00:25.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":117500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":117500,"derivative":{"underlying":"Common stock","underlying_shares":117500},"source":{"system":"sec-edgar","filing":"0001104659-26-026442","document":"tm268453-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926026442/tm268453-1_4seq1.xml","form_type":"4"}},{"id":855954,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T22:02:10.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":62493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":125007,"derivative":{"underlying":"Common stock","underlying_shares":62493},"source":{"system":"sec-edgar","filing":"0001104659-26-024765","document":"tm268187-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926024765/tm268187-4_4seq1.xml","form_type":"4"}},{"id":855953,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-06T22:02:10.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":26755,"price":4.58,"value":122537.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":529538,"source":{"system":"sec-edgar","filing":"0001104659-26-024765","document":"tm268187-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926024765/tm268187-4_4seq1.xml","form_type":"4"}},{"id":855952,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-06T22:02:10.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":62493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":556293,"source":{"system":"sec-edgar","filing":"0001104659-26-024765","document":"tm268187-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926024765/tm268187-4_4seq1.xml","form_type":"4"}},{"id":855984,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T22:01:35.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":31246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":62504,"derivative":{"underlying":"Common stock","underlying_shares":31246},"source":{"system":"sec-edgar","filing":"0001104659-26-024762","document":"tm268187-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926024762/tm268187-3_4seq1.xml","form_type":"4"}},{"id":855983,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:01:35.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":16520,"price":4.58,"value":75661.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":131957,"source":{"system":"sec-edgar","filing":"0001104659-26-024762","document":"tm268187-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926024762/tm268187-3_4seq1.xml","form_type":"4"}},{"id":855982,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:01:35.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":31246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":148477,"source":{"system":"sec-edgar","filing":"0001104659-26-024762","document":"tm268187-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926024762/tm268187-3_4seq1.xml","form_type":"4"}},{"id":856270,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T22:00:45.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":39059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":78131,"derivative":{"underlying":"Common stock","underlying_shares":39059},"source":{"system":"sec-edgar","filing":"0001104659-26-024760","document":"tm268187-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926024760/tm268187-2_4seq1.xml","form_type":"4"}},{"id":856269,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:00:45.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":18360,"price":4.58,"value":84088.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":239230,"source":{"system":"sec-edgar","filing":"0001104659-26-024760","document":"tm268187-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926024760/tm268187-2_4seq1.xml","form_type":"4"}},{"id":856268,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:00:45.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":39059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":257590,"source":{"system":"sec-edgar","filing":"0001104659-26-024760","document":"tm268187-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926024760/tm268187-2_4seq1.xml","form_type":"4"}},{"id":855770,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T22:00:12.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":31246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":62504,"derivative":{"underlying":"Common stock","underlying_shares":31246},"source":{"system":"sec-edgar","filing":"0001104659-26-024759","document":"tm268187-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926024759/tm268187-1_4seq1.xml","form_type":"4"}},{"id":855769,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:00:12.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":16628,"price":4.58,"value":76156.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":125766,"source":{"system":"sec-edgar","filing":"0001104659-26-024759","document":"tm268187-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926024759/tm268187-1_4seq1.xml","form_type":"4"}},{"id":855768,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:00:12.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":31246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":142394,"source":{"system":"sec-edgar","filing":"0001104659-26-024759","document":"tm268187-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926024759/tm268187-1_4seq1.xml","form_type":"4"}},{"id":861656,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":10418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":10418},"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861655,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":166675,"derivative":{"underlying":"Common stock","underlying_shares":41669},"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861654,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":22809,"price":3.79,"value":86446.11,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":493800,"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861653,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":52087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":516609,"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861275,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:01:14.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":3517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":3517},"source":{"system":"sec-edgar","filing":"0001104659-26-023538","document":"tm267902-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926023538/tm267902-3_4seq1.xml","form_type":"4"}},{"id":861274,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:01:14.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":35159,"derivative":{"underlying":"Common stock","underlying_shares":8790},"source":{"system":"sec-edgar","filing":"0001104659-26-023538","document":"tm267902-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926023538/tm267902-3_4seq1.xml","form_type":"4"}},{"id":861273,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:01:14.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6903,"price":3.79,"value":26162.37,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":111148,"source":{"system":"sec-edgar","filing":"0001104659-26-023538","document":"tm267902-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926023538/tm267902-3_4seq1.xml","form_type":"4"}},{"id":861272,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2091,"kind":"person","name":"BILINSKY IGOR","position":1,"cik":"0001594604","reported_name":"BILINSKY IGOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:01:14.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":12307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":118051,"source":{"system":"sec-edgar","filing":"0001104659-26-023538","document":"tm267902-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926023538/tm267902-3_4seq1.xml","form_type":"4"}},{"id":862357,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:00:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":5470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":21878,"derivative":{"underlying":"Common stock","underlying_shares":5470},"source":{"system":"sec-edgar","filing":"0001104659-26-023537","document":"tm267902-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926023537/tm267902-2_4seq1.xml","form_type":"4"}},{"id":862356,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:44.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2798,"price":3.79,"value":10604.42,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":218531,"source":{"system":"sec-edgar","filing":"0001104659-26-023537","document":"tm267902-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926023537/tm267902-2_4seq1.xml","form_type":"4"}},{"id":862355,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2102,"kind":"person","name":"Puri Raj K.","position":1,"cik":"0002046483","reported_name":"Puri Raj K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":5470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":221329,"source":{"system":"sec-edgar","filing":"0001104659-26-023537","document":"tm267902-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046483/000110465926023537/tm267902-2_4seq1.xml","form_type":"4"}},{"id":861737,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:00:14.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":3907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":3907},"source":{"system":"sec-edgar","filing":"0001104659-26-023535","document":"tm267902-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926023535/tm267902-1_4seq1.xml","form_type":"4"}},{"id":861736,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:00:14.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":35159,"derivative":{"underlying":"Common stock","underlying_shares":8790},"source":{"system":"sec-edgar","filing":"0001104659-26-023535","document":"tm267902-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926023535/tm267902-1_4seq1.xml","form_type":"4"}},{"id":861735,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:14.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":7122,"price":3.79,"value":26992.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":117231,"source":{"system":"sec-edgar","filing":"0001104659-26-023535","document":"tm267902-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926023535/tm267902-1_4seq1.xml","form_type":"4"}},{"id":861734,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:14.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":12697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":124353,"source":{"system":"sec-edgar","filing":"0001104659-26-023535","document":"tm267902-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465926023535/tm267902-1_4seq1.xml","form_type":"4"}},{"id":880044,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-26T22:00:18.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 10, 2025, the Reporting Person was granted an award of up to 150,000 PSUs, which vests in the form of shares of the Issuer's common stock upon the achievement of certain financial milestones. On February 24, 2026, certain financial milestones were met, resulting in the vesting of the PSUs as to 120,000 of the underlying shares and the cancellation of the PSUs as to 30,000 of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 10, 2025, the Reporting Person was granted an award of up to 150,000 PSUs, which vests in the form of shares of the Issuer's common stock upon the achievement of certain financial milestones. On February 24, 2026, certain financial milestones were met, resulting in the vesting of the PSUs as to 120,000 of the underlying shares and the cancellation of the PSUs as to 30,000 of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-26-020613","document":"tm267318-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926020613/tm267318-1_4seq1.xml","form_type":"4"}},{"id":880043,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:00:18.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":34165,"price":3.78,"value":129143.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the PSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":139381,"source":{"system":"sec-edgar","filing":"0001104659-26-020613","document":"tm267318-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926020613/tm267318-1_4seq1.xml","form_type":"4"}},{"id":880042,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:00:18.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock underlying performance-based restricted stock units (\"PSUs\") that have been earned based on the level of achievement of certain financial milestones. The earned PSUs vested on February 24, 2026."}],"balance_after":173546,"source":{"system":"sec-edgar","filing":"0001104659-26-020613","document":"tm267318-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926020613/tm267318-1_4seq1.xml","form_type":"4"}},{"id":907887,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-12T22:00:14.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":false,"shares":39996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":80004,"derivative":{"underlying":"Common Stock","underlying_shares":39996},"source":{"system":"sec-edgar","filing":"0001104659-26-014400","document":"tm266006-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926014400/tm266006-1_4seq1.xml","form_type":"4"}},{"id":907886,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T22:00:14.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":16450,"price":2.6,"value":42770.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":53546,"source":{"system":"sec-edgar","filing":"0001104659-26-014400","document":"tm266006-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926014400/tm266006-1_4seq1.xml","form_type":"4"}},{"id":907885,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24238,"kind":"person","name":"Kirby Daniel Gordon","position":1,"cik":"0002055001","reported_name":"Kirby Daniel Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T22:00:14.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":true,"shares":39996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":69996,"source":{"system":"sec-edgar","filing":"0001104659-26-014400","document":"tm266006-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055001/000110465926014400/tm266006-1_4seq1.xml","form_type":"4"}},{"id":981660,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-03T22:04:04.000Z","date":"2025-12-02","kind":"exercise","planned":false,"acquired":false,"shares":3906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":3907,"derivative":{"underlying":"Common stock","underlying_shares":3906},"source":{"system":"sec-edgar","filing":"0001104659-25-118170","document":"tm2532666-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465925118170/tm2532666-4_4seq1.xml","form_type":"4"}},{"id":981659,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":40074,"kind":"person","name":"GRAF FINCKENSTEIN FRIEDRICH","position":1,"cik":"0001782981","reported_name":"GRAF FINCKENSTEIN FRIEDRICH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-03T22:04:04.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":8789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":43949,"derivative":{"underlying":"Common stock","underlying_shares":8789},"source":{"system":"sec-edgar","filing":"0001104659-25-118170","document":"tm2532666-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782981/000110465925118170/tm2532666-4_4seq1.xml","form_type":"4"}}],"next_cursor":"2025-12-03T22:04:04.000000Z,981659"}